DASH Pharmaceuticals LLC recalls Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 ca
Recalled April 13, 2022 · FDA recall D-0749-2022 · DASH Pharmaceuticals
Hazard
Labeling: Label Mix-Up · FDA Class II
Units
45,940 Unit Dose Cups
Sold at
Nationwide within the United States
Description
Labeling: Label Mix-Up
Product
Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 case of 10 mL Unit Dose Cups (NDC 69339-148-19) Rx Only, Dash Pharmaceuticals, Upper Saddle River, NJ 07458.
Manufacturer(s)
DASH Pharmaceuticals LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →